MOTIVATION: The Encyclopedia of Domains (TED) provides domain annotations for proteins in the AlphaFold Protein Structure Database (AFDB) using a consensus of three state-of-the-art structure-based methods. We used these annotations to construct profile Hidden Markov models (HMMs), collectively forming the TED Library of HMMs (TEDLH). TEDLH enables sensitive sequence and profile searches, supporting systematic exploration of protein domain families and their evolutionary relationships. RESULTS: TEDLH links 934,186 domain HMMs to experimentally determined CATH-PDB structures through direct (primary) and transitive (secondary and tertiary) relationships. Fewer than half of TEDLH HMMs are directly linked to a CATH-PDB domain; the remaining models are connected through transitive relationships. These transitive links extend coverage into more divergent regions of sequence space and better represent CATH superfamily diversity. HMM-HMM comparisons within CATH superfamily 3.30.70.100 illustrate how transitive relationships expand sequence coverage. In this superfamily, 5640 TEDLH HMMs are connected to 173 CATH-PDB representatives. Primary, secondary, and tertiary relationships progressively capture more divergent sequences (pairwise sequence identity <20%) that retain structural similarity (TM-score ≥0.6) and a conserved two-layer α/β sandwich core fold. All-against-all HMM-HMM comparisons across TEDLH also reveal sequence similarities across the CATH hierarchy (cross-hits). At low query coverage (<50%), cross-hits are more frequent between CATH classes, architectures and topologies, whereas at higher coverage thresholds (≥70%) they predominantly occur between superfamilies. These cross-hits are not driven by superfamily size or sequence diversity and can provide guidance for CATH curation. As an example, analysis of cross-hits between superfamilies 2.170.130.30 and 3.10.20.30 reveals evolutionary relationships between these groups. AVAILABILITY: TEDLH is compatible with HH-suite3 and is available from FigShare https://doi.org/10.6084/m9.figshare.28531754 for local use.

MOTIVATION: CATH is a protein domain classification resource that exploits an automated workflow of structure and sequence comparison alongside expert manual curation to construct a hierarchical classification of evolutionary and structural relationships. The aim of this study was to develop algorithms for detecting remote homologues missed by state-of-the-art hidden Markov model (HMM)-based approaches. The method developed (CATHe) combines a neural network with sequence representations obtained from protein language models. It was assessed using a dataset of remote homologues having less than 20% sequence identity to any domain in the training set. RESULTS: The CATHe models trained on 1773 largest and 50 largest CATH superfamilies had an accuracy of 85.6 ± 0.4% and 98.2 ± 0.3%, respectively. As a further test of the power of CATHe to detect more remote homologues missed by HMMs derived from CATH domains, we used a dataset consisting of protein domains that had annotations in Pfam, but not in CATH. By using highly reliable CATHe predictions (expected error rate <0.5%), we were able to provide CATH annotations for 4.62 million Pfam domains. For a subset of these domains from Homo sapiens, we structurally validated 90.86% of the predictions by comparing their corresponding AlphaFold2 structures with structures from the CATH superfamilies to which they were assigned. AVAILABILITY AND IMPLEMENTATION: The code for the developed models is available on https://github.com/vam-sin/CATHe, and the datasets developed in this study can be accessed on https://zenodo.org/record/6327572. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online.

SARS-CoV-2 is the causative agent of COVID-19, the ongoing global pandemic. It has posed a worldwide challenge to human health as no effective treatment is currently available to combat the disease. Its severity has led to unprecedented collaborative initiatives for therapeutic solutions against COVID-19. Studies resorting to structure-based drug design for COVID-19 are plethoric and show good promise. Structural biology provides key insights into 3D structures, critical residues/mutations in SARS-CoV-2 proteins, implicated in infectivity, molecular recognition and susceptibility to a broad range of host species. The detailed understanding of viral proteins and their complexes with host receptors and candidate epitope/lead compounds is the key to developing a structure-guided therapeutic design. Since the discovery of SARS-CoV-2, several structures of its proteins have been determined experimentally at an unprecedented speed and deposited in the Protein Data Bank. Further, specialized structural bioinformatics tools and resources have been developed for theoretical models, data on protein dynamics from computer simulations, impact of variants/mutations and molecular therapeutics. Here, we provide an overview of ongoing efforts on developing structural bioinformatics tools and resources for COVID-19 research. We also discuss the impact of these resources and structure-based studies, to understand various aspects of SARS-CoV-2 infection and therapeutic development. These include (i) understanding differences between SARS-CoV-2 and SARS-CoV, leading to increased infectivity of SARS-CoV-2, (ii) deciphering key residues in the SARS-CoV-2 involved in receptor-antibody recognition, (iii) analysis of variants in host proteins that affect host susceptibility to infection and (iv) analyses facilitating structure-based drug and vaccine design against SARS-CoV-2.